Abstract/Journal Article DZNE-2020-00843

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
O4: Phenotype, neuropsychology and psychopathology ofC9orf72 mutation carriers from the German FTLD-Consortium

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2016

10th International Conference on Frontotemporal Dementias, MunichMunich, Germany, 31 Aug 2016 - 2 Sep 20162016-08-312016-09-02 Journal of neurochemistry 138(Supplement 1), 227 ()

Abstract: It has been suggested, that the clinical phenotype of behavioralvariant frontotemporal dementia (bvFTD) patients with C9orf72mutation differs from non-carriers. It has been stated, that distur-bances of episodic memory as well as psychotic symptoms are morefrequent in C9orf72 mutation carriers and that mutation carriers lesslikely meet the diagnostic criteria for bvFTD.From 386 tested, 23 bvFTD-patients with C9orf72 mutationswere identified in the German FTLD-Consortium. Firstly, it wasrated, if the patients fulfilled the diagnostic criteria for possible orprobable bvFTD. In a second step, mutation carriers with earlybvFTD (< 5 years after onset, N = 16) were identified andneuropsychological test performance, psychopathology and imagingwas compared to non-mutation carriers with early probable bvFTD.Among the mutation carriers one patient had a “psychiatric ”phenotype with severe hallucinations of body sensations. Onepatient had a 10 year long history of therapy-refractory depressionbefore symptoms of bvFTD occurred and one patient showedclinical symptoms typical for Alzheimer’s disease. In the group ofearly bvFTD patients no significant differences were detectedbetween mutation carriers and non-mutation carriers regarding theprevalence of cognitive and psychiatric symptoms. None of themutation carriers suffered from visual or auditory hallucinations.Likewise, no significant differences were detected regardingneuropsychological test performance. However, there was a (statis-tically not significant) trend that forgetfulness was more oftenreported as first symptom in mutation carriers than in non-carriers. Apreliminary analysis revealed no significant differences in MRI- andPET imaging, a finding that needs, however, to be confirmed infurther voxel based analyses. Taken together, results do not support the hypothesis thatphenotypes of C9orf72 mutation carriers differ from non-carriers. Aselection bias, however, needs to be considered

Classification:

Contributing Institute(s):
  1. Patient studies (Patient studies, Bonn)
Research Program(s):
  1. 344 - Clinical and Health Care Research (POF3-344) (POF3-344)

Appears in the scientific report 2016
Database coverage:
Medline ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DEAL Wiley ; Ebsco Academic Search ; Essential Science Indicators ; IF < 5 ; JCR ; NCBI Molecular Biology Database ; NationallizenzNationallizenz ; SCOPUS ; Science Citation Index ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Institute Collections > BN DZNE > BN DZNE-Patient Studies (Bonn)
Document types > Articles > Journal Article
Document types > Presentations > Abstracts
Public records
Publications Database

 Record created 2020-08-07, last modified 2020-09-25


External link:
Download fulltext
Fulltext
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)